Association between premature vascular smooth muscle cells senescence and vascular inflammation in Takayasu's arteritis
Open Access
- 30 May 2024
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 83 (11) , 1522-1535
Abstract
Objectives Arterial wall inflammation and remodelling are the characteristic features of Takayasu’s arteritis (TAK). It has been proposed that vascular smooth muscle cells (VSMCs) are the main targeted cells of inflammatory damage and participate in arterial remodelling in TAK. Whether VSMCs are actively involved in arterial wall inflammation has not been elucidated. Studies have shown that cellular senescence in tissue is closely related to local inflammation persistence. We aimed to investigate whether VSMCs senescence contributes to vascular inflammation and the prosenescent factors in TAK. Methods VSMCs senescence and senescence-associated secretory phenotype were detected by histological examination, bulk RNA-Seq and single-cell RNA-seq conducted on vascular surgery samples of TAK patients. The key prosenescent factors and the downstream signalling pathway were investigated in a series of in vitro and ex vivo experiments. Results Histological findings, primary cell culture and transcriptomic analyses demonstrated that VSMCs of TAK patients had the features of premature senescence and contributed substantially to vascular inflammation by upregulating the expression of senescence-associated inflammatory cytokines. IL-6 was found to be the critical cytokine that drove VSMCs senescence and senescence-associated mitochondrial dysfunction in TAK. Mechanistically, IL-6-induced non-canonical mitochondrial localisation of phosphorylated STAT3 (Tyr705) prevented mitofusin 2 (MFN2) from proteasomal degradation, and subsequently promoted senescence-associated mitochondrial dysfunction and VSMCs senescence. Mitochondrial STAT3 or MFN2 inhibition ameliorated VSMCs senescence in ex vivo cultured arteries of TAK patients. Conclusions VSMCs present features of cellular senescence and are actively involved in vascular inflammation in TAK. Vascular IL-6-mitochondrial STAT3-MFN2 signalling is an important driver of VSMCs senescence.Keywords
Funding Information
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine (2021-I2M-1–005)
- National High Level Hospital Clinical Research Funding (2022-PUMCH-B-013, 2022-PUMCH-D-009, BJ-2021-196)
- National Key Research and Development Project of China (2019YFC0840603, 2020YFC2008003)
This publication has 36 references indexed in Scilit:
- Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 casesSeminars in Arthritis and Rheumatism, 2023
- The effectiveness of tocilizumab and its comparison with tumor necrosis factor alpha inhibitors for Takayasu Arteritis: A systematic review and meta-analysisAutoimmunity Reviews, 2023
- Hallmarks of aging: An expanding universeCell, 2023
- Interleukin‐1 pathway in active large vessel vasculitis patients with a poor prognosis: a longitudinal transcriptome analysisClinical & Translational Immunology, 2021
- Cardiovascular Manifestations of Systemic VasculitidesCurrent Rheumatology Reports, 2020
- Cellular Senescence: Defining a Path ForwardCell, 2019
- Vascular calcification in patients with large-vessel vasculitis compared to patients with hyperlipidemiaSeminars in Arthritis and Rheumatism, 2019
- Responses of vascular smooth muscle cells to estrogen are dependent on balance between ERK and p38 MAPK pathway activitiesInternational Journal of Cardiology, 2009
- Atherosclerosis in patients with biopsy‐proven giant cell arteritisArthritis Care & Research, 2007
- Estrogen accelerates G1 to S phase transition and induces a G2/M phase-predominant apoptosis in synthetic vascular smooth muscle cellsInternational Journal of Cardiology, 2007